Royal London Asset Management LTD Becton Dickinson & CO Transaction History

Royal London Asset Management LTD

  • $39.4 Billion
  • Q3 2024

A detailed history of Royal London Asset Management LTD transactions in Becton Dickinson & CO stock. As of the latest transaction made, Royal London Asset Management LTD holds 130,826 shares of BDX stock, worth $29.3 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
130,826
Previous 126,465 3.45%
Holding current value
$29.3 Million
Previous $29.6 Million 6.72%
% of portfolio
0.08%
Previous 0.08%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$221.47 - $242.41 $965,830 - $1.06 Million
4,361 Added 3.45%
130,826 $31.5 Million
Q2 2024

Aug 07, 2024
SELL
$225.07 - $246.17 $101,506 - $111,022
-451 Reduced 0.36%
126,465 $29.6 Million
Q1 2024

May 14, 2024
BUY
$233.45 - $247.73 $1.49 Million - $1.58 Million
6,384 Added 5.3%
126,916 $31.4 Million
Q4 2023

Feb 13, 2024
BUY
$232.24 - $267.23 $1.86 Million - $2.15 Million
8,029 Added 7.14%
120,532 $29.4 Million
Q3 2023

Nov 14, 2023
BUY
$254.9 - $283.59 $483,545 - $537,970
1,897 Added 1.72%
112,503 $29.1 Million
Q2 2023

Aug 11, 2023
BUY
$238.39 - $265.32 $1.31 Million - $1.46 Million
5,492 Added 5.22%
110,606 $29.2 Million
Q1 2023

May 15, 2023
BUY
$229.71 - $259.35 $623,662 - $704,135
2,715 Added 2.65%
105,114 $26 Million
Q4 2022

Feb 09, 2023
BUY
$218.29 - $256.91 $567,554 - $667,966
2,600 Added 2.61%
102,399 $26 Million
Q3 2022

Nov 14, 2022
SELL
$51.03 - $264.23 $228,053 - $1.18 Million
-4,469 Reduced 4.29%
99,799 $22.2 Million
Q2 2022

Aug 12, 2022
BUY
$234.74 - $275.42 $784,031 - $919,902
3,340 Added 3.31%
104,268 $25.7 Million
Q1 2022

May 13, 2022
BUY
$243.64 - $270.48 $792,073 - $879,330
3,251 Added 3.33%
100,928 $26.9 Million
Q4 2021

Oct 18, 2022
SELL
$230.08 - $250.94 $1.47 Million - $1.6 Million
-6,370 Reduced 6.12%
97,677 $24.6 Million
Q4 2021

Jan 18, 2022
SELL
$230.08 - $250.94 $1.47 Million - $1.6 Million
-6,370 Reduced 6.12%
97,677 $24.6 Million
Q3 2021

Oct 18, 2022
SELL
$232.72 - $256.47 $275,773 - $303,916
-1,185 Reduced 1.13%
104,047 $25.6 Million
Q3 2021

Nov 02, 2021
SELL
$232.72 - $256.47 $275,773 - $303,916
-1,185 Reduced 1.13%
104,047 $25.6 Million
Q2 2021

Oct 18, 2022
BUY
$232.65 - $254.58 $224,274 - $245,415
964 Added 0.92%
105,232 $25.6 Million
Q1 2021

Oct 17, 2022
BUY
$232.09 - $256.88 $223,734 - $247,632
964 Added 0.92%
105,232 $25.6 Million
Q1 2021

Apr 13, 2021
BUY
$232.09 - $256.88 $1.09 Million - $1.21 Million
4,707 Added 4.68%
105,232 $25.6 Million
Q4 2020

Jan 29, 2021
SELL
$221.92 - $245.94 $578,323 - $640,919
-2,606 Reduced 2.53%
100,525 $25.2 Million
Q2 2020

Jul 31, 2020
SELL
$219.9 - $263.41 $886,416 - $1.06 Million
-4,031 Reduced 3.76%
103,131 $24 Million
Q1 2020

May 01, 2020
SELL
$195.69 - $279.01 $37,963 - $54,127
-194 Reduced 0.18%
107,162 $23.9 Million
Q4 2019

Feb 05, 2020
SELL
$236.45 - $266.82 $663,951 - $749,230
-2,808 Reduced 2.55%
107,356 $29 Million
Q3 2019

Nov 12, 2019
BUY
$230.58 - $256.08 $25.4 Million - $28.2 Million
110,164 New
110,164 $26.8 Million
Q2 2019

Jul 31, 2019
SELL
$217.4 - $246.08 $22.4 Million - $25.4 Million
-103,067 Closed
0 $0
Q1 2019

Apr 30, 2019
SELL
$206.05 - $248.17 $2.28 Million - $2.74 Million
-11,049 Reduced 9.68%
103,067 $0
Q4 2018

Jan 29, 2019
BUY
$204.73 - $257.93 $23.4 Million - $29.4 Million
114,116 New
114,116 $25.3 Million
Q3 2018

Nov 08, 2018
SELL
$233.07 - $256.0 $25.4 Million - $27.9 Million
-108,833 Closed
0 $0
Q2 2018

Sep 19, 2018
BUY
$208.1 - $233.85 $22.6 Million - $25.5 Million
108,833 New
108,833 $26.1 Million

Others Institutions Holding BDX

# of Institutions
1,737
Shares Held
250M
Call Options Held
690K
Put Options Held
787K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Royal London Asset Management LTD Portfolio

Follow Royal London Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Royal London Asset Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email